Karaman, Olha, et al. “CD19 Chimeric Antigen Receptor (CAR) Modified Cytokine Killer Cells Compared to Classical CD19 CAR-T: Advantages and Disadvantages”. South East European Journal of Immunology, vol. 8, no. CITIM, Mar. 2025, p. 062, doi:10.3889/seejim.2025.6123.